Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study

被引:8
|
作者
David, Allison R. [1 ]
Sian, Carlos R. [2 ]
Gebel, Christina M.
Linas, Benjamin P. [2 ,3 ,4 ]
Samet, Jeffrey H. [1 ]
Martinez, Linda S. Sprague [5 ]
Muroff, Jordana [5 ]
Bernstein, Judith A.
Assoumou, Sabrina A. [2 ,3 ,4 ]
机构
[1] Boston Med Ctr, Dept Med, 72 East Concord St,Evans 124, Boston, MA 02118 USA
[2] Boston Med Ctr, Crosstown Ctr, Sect Infect Dis, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA
[3] Boston Univ, Sch Publ Hlth, Crosstown Ctr, 801 Massachusetts Ave, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Crosstown Ctr, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA
[5] Boston Univ, Sch Social Work, 264 Bay State Rd, Boston, MA 02215 USA
关键词
Drug detoxification center; People who inject drugs; Continuity of care; Linkage to care; Access to care; Medications for opioid use disorder; OPIATE DETOXIFICATION; USE DISORDERS; FOLLOW-UP; ADHERENCE;
D O I
10.1016/j.jsat.2022.108870
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Access to and uptake of evidence-based treatment for substance use disorder, specifically opioid use disorder (OUD), are limited despite the high death toll from drug overdose in the United States in recent years. Patient perceived barriers to evidence-based treatment after completion of short-term inpatient medically managed withdrawal programs (detox) have not been well studied. The purpose of the current study is to elicit patients' perspectives on challenges to transition to treatment, including medications for OUD (MOUD), after detox and potential solutions. Methods: We conducted semi-structured interviews (N = 24) at a detox center (2018-2019) to explore patients' perspectives on obstacles to treatment. The study managed the data in NVivo and we used content analysis to identify themes. Results: Patients' characteristics included the following: 54 % male; mean age 37 years; self-identified as White 67 %, Black 13 %, Latinx 8 %, Native Hawaiian/Pacific Islander 4 %, and other 8 %; heroin use in the past 3 months 67 %; and ever injecting drugs 71 %. Patients identified the following barriers: 1) lack of continuity of care; 2) limited number of detox and residential treatment program beds; 3) unstable housing; and 4) lack of options when choosing a treatment pathway. Solutions proposed by participants included: 1) increase low -barrier access to community MOUD; 2) add case managers at the detox center to establish continuity of care after discharge; 3) increase assistance with housing; and 4) encourage patient participation in treatment decisions. Conclusions: Patients identified lack of continuity of care, especially care coordination, as a major barrier to substance use treatment. Increasing treatment utilization, including MOUD, necessitates a multimodal approach to continuity of care, low-barrier access to MOUD, and support to address unstable housing. Patients want care that incorporates options and respect for. individualized preferences and needs.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Barriers and facilitators for social inclusion among people with concurrent mental health and substance use problems. A qualitative scoping review
    Nord-Baade, Silje
    Ness, Ottar
    Jensen, Camilla Bergsve
    Rowe, Michael
    Opheim, Elin
    Landheim, Anne
    PLOS ONE, 2024, 19 (12):
  • [42] Barriers to access and re-attendance for treatment of podoconiosis: a qualitative study in northern Ethiopia
    Tsegay, Girmay
    Wubie, Moges
    Degu, Genet
    Tamiru, Abreham
    Cooper, Max
    Davey, Gail
    INTERNATIONAL HEALTH, 2015, 7 (04): : 285 - 292
  • [43] Barriers to prophylactic treatment among patients with haemophilia A in Shandong Province, China: a qualitative study
    Ziyu Liu
    Junchao Feng
    Yunhai Fang
    Yan Cheng
    Shunping Li
    Orphanet Journal of Rare Diseases, 18
  • [44] Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study
    Farhoudi, Behnam
    Alipour, Amin
    Ghodrati, Saeed
    Seyedalinaghi, Seyedahmad
    Zanganeh, Mehrangiz
    Mohraz, Minoo
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2018, 13 (02):
  • [45] Barriers to prophylactic treatment among patients with haemophilia A in Shandong Province, China: a qualitative study
    Liu, Ziyu
    Feng, Junchao
    Fang, Yunhai
    Cheng, Yan
    Li, Shunping
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [46] Migrants' Perceptions on Barriers to Treatment Seeking for Hypertension: A Qualitative Study from Delhi, India
    Kusuma, Yadlapalli S.
    STUDIES ON ETHNO-MEDICINE, 2010, 4 (03) : 173 - 176
  • [47] Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative study
    Hsiang, Elaine
    Patel, Kishan
    Wilson, Erin C.
    Dunham, Alexandrea
    Ikeda, Janet
    Matheson, Tim
    Santos, Glenn-Milo
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2024, 19 (01):
  • [48] Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone
    Nunes, Edward V.
    Gordon, Michael
    Friedmann, Peter D.
    Fishman, Marc J.
    Lee, Joshua D.
    Chen, Donna T.
    Hu, Mei Chen
    Boney, Tamara Y.
    Wilson, Donna
    O'Brien, Charles P.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 85 : 49 - 55
  • [49] Targeting Consumers in the Early Stages of Substance Use Treatment: A Pilot Study
    Davis, Kristin E.
    Devitt, Tim
    O'Neill, Sheila
    Kaiser, Susan M.
    Mueser, Kim T.
    PSYCHIATRIC REHABILITATION JOURNAL, 2014, 37 (01) : 37 - 42
  • [50] South African service users' perceptions of patient-reported outcome and experience measures for adolescent substance use treatment: A qualitative study
    Myers, Bronwyn
    Johnson, Kim
    Lucas, Warren
    Govender, Rajen
    Manderscheid, Ron
    Williams, Petal Petersen
    Koch, J. Randy
    DRUG AND ALCOHOL REVIEW, 2019, 38 (07) : 823 - 830